UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 76

Sortiert nach

Targeting Mitosis in Cancer: Emerging Strategies

Molecular cell, 2015-11, Vol.60 (4), p.524-536

2015

Volltextzugriff (PDF)

Genomic deregulation of the E2F/Rb pathway leads to activation of the oncogene EZH2 in small cell lung cancer

PloS one, 2013-08, Vol.8 (8), p.e71670-e71670

2013

Volltextzugriff (PDF)

Unique somatic and malignant expression patterns implicate PIWI-interacting RNAs in cancer-type specific biology

Scientific reports, 2015-05, Vol.5 (1), p.10423-10423, Article 10423

2015

Volltextzugriff (PDF)

Gene isoforms as expression-based biomarkers predictive of drug response in vitro

Nature communications, 2017-10, Vol.8 (1), p.1126-11, Article 1126

2017

Volltextzugriff (PDF)

Polo-like kinase 4 inhibition produces polyploidy and apoptotic death of lung cancers

Proceedings of the National Academy of Sciences - PNAS, 2018-02, Vol.115 (8), p.1913-1918

2018

Volltextzugriff (PDF)

Noncoding somatic and inherited single-nucleotide variants converge to promote ESR1 expression in breast cancer

Nature genetics, 2016-10, Vol.48 (10), p.1260-1266

2016

Volltextzugriff (PDF)

Lung adenocarcinoma of never smokers and smokers harbor differential regions of genetic alteration and exhibit different levels of genomic instability

PloS one, 2012-03, Vol.7 (3), p.e33003-e33003

2012

Volltextzugriff (PDF)

CD47: The Next Frontier in Immune Checkpoint Blockade for Non-Small Cell Lung Cancer

Cancers, 2023-10, Vol.15 (21), p.5229

2023

Volltextzugriff (PDF)

Divergent genomic and epigenomic landscapes of lung cancer subtypes underscore the selection of different oncogenic pathways during tumor development

PloS one, 2012-05, Vol.7 (5), p.e37775

2012

Volltextzugriff (PDF)

Plug and Pop: A 3D-Printed, Modular Platform for Drug Delivery Using Clinical Ultrasound and Microbubbles

Pharmaceutics, 2022-11, Vol.14 (11), p.2516

2022

Volltextzugriff (PDF)

Identification of the epigenetic reader CBX2 as a potential drug target in advanced prostate cancer

Clinical epigenetics, 2016-02, Vol.8 (16), p.16-16, Article 16

2016

Volltextzugriff (PDF)

Integrative Genomics Identified RFC3 As an Amplified Candidate Oncogene in Esophageal Adenocarcinoma

Clinical cancer research, 2012-04, Vol.18 (7), p.1936-1946

2012

Volltextzugriff (PDF)

Integrative genomic analyses identify BRF2 as a novel lineage-specific oncogene in lung squamous cell carcinoma

PLoS medicine, 2010-07, Vol.7 (7), p.e1000315-e1000315

2010

Volltextzugriff (PDF)

Author Correction: Gene isoforms as expression-based biomarkers predictive of drug response in vitro

Nature communications, 2018-01, Vol.9 (1), p.166-166, Article 166

2018

Volltextzugriff (PDF)

Smoking status impacts microRNA mediated prognosis and lung adenocarcinoma biology

BMC cancer, 2014-10, Vol.14 (1), p.778-778, Article 778

2014

Volltextzugriff (PDF)

miR-101 DNA Copy Loss is a Prominent Subtype Specific Event in Lung Cancer

Journal of thoracic oncology, 2011-09, Vol.6 (9), p.1594-1598

2011

Volltextzugriff (PDF)

Unique Pattern of Component Gene Disruption in the NRF2 Inhibitor KEAP1/CUL3/RBX1 E3-Ubiquitin Ligase Complex in Serous Ovarian Cancer

BioMed research international, 2014-01, Vol.2014, p.159459-10

2014

Volltextzugriff (PDF)

Genetic Disruption of KEAP1/CUL3 E3 Ubiquitin Ligase Complex Components is a Key Mechanism of NF-KappaB Pathway Activation in Lung Cancer

Journal of thoracic oncology, 2011-09, Vol.6 (9), p.1521-1529

2011

Volltextzugriff (PDF)

Acquired Resistance to EGFR Inhibitors Is Associated with a Manifestation of Stem Cell-like Properties in Cancer Cells

Cancer research (Chicago, Ill.), 2013-05, Vol.73 (10), p.3051-3061

2013

Volltextzugriff (PDF)

Re: the Wnt signaling pathway in non-small cell lung cancer

JNCI : Journal of the National Cancer Institute, 2014-08, Vol.106 (8), p.dju188-dju188

2014

Volltextzugriff (PDF)

ATM—the gene at the moment in non-small cell lung cancer

Translational lung cancer research, 2024-03, Vol.13 (3), p.699-705

2024

Volltextzugriff (PDF)

AhR controls redox homeostasis and shapes the tumor microenvironment in BRCA1-associated breast cancer

Proceedings of the National Academy of Sciences - PNAS, 2019-02, Vol.116 (9), p.3604-3613

2019

Volltextzugriff (PDF)

Lysophosphatidic Acid Receptor 1 (LPA1) Antagonists as Potential Migrastatics for Triple Negative Breast Cancer

ChemMedChem, 2024-08, Vol.19 (16), p.e202400013-n/a

2024

Volltextzugriff (PDF)

EZH2 Promotes E2F-Driven SCLC Tumorigenesis through Modulation of Apoptosis and Cell-Cycle Regulation

Journal of thoracic oncology, 2013-08, Vol.8 (8), p.1102-1106

2013

Volltextzugriff (PDF)

1 – 25 von 76

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(72)
Mit Volltextzugriff
(73)

Publikationsform

Artikel
(75)
Buchkapitel
(1)

Sprache

Englisch
(76)
Japanisch
(18)

Erscheinungsjahr

n.n

Thema

Science & Technology
(48)
Humans
(38)
Life Sciences & Biomedicine
(37)
Oncology
(27)
Lung Cancer
(14)
Cancer
(13)
Tumors
(13)
Animals
(12)
Female
(12)
Lung Neoplasms - Pathology
(12)
Mutation
(12)
Gene Expression
(11)
Gene Expression Regulation, Neoplastic
(11)
Lung Neoplasms - Genetics
(11)
Multidisciplinary Sciences
(11)
Science & Technology - Other Topics
(11)
Cell Line, Tumor
(10)
Genomics
(10)
Genomes
(9)
Prognosis
(9)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Targeting Mitosis in Cancer: Emerging Strategies

Genomic deregulation of the E2F/Rb pathway leads to activation of the oncogene EZH2 in small cell lung cancer

Unique somatic and malignant expression patterns implicate PIWI-interacting RNAs in cancer-type specific biology

Gene isoforms as expression-based biomarkers predictive of drug response in vitro

Polo-like kinase 4 inhibition produces polyploidy and apoptotic death of lung cancers

Noncoding somatic and inherited single-nucleotide variants converge to promote ESR1 expression in breast cancer

Lung adenocarcinoma of never smokers and smokers harbor differential regions of genetic alteration and exhibit different levels of genomic instability

CD47: The Next Frontier in Immune Checkpoint Blockade for Non-Small Cell Lung Cancer

Divergent genomic and epigenomic landscapes of lung cancer subtypes underscore the selection of different oncogenic pathways during tumor development

Plug and Pop: A 3D-Printed, Modular Platform for Drug Delivery Using Clinical Ultrasound and Microbubbles

Identification of the epigenetic reader CBX2 as a potential drug target in advanced prostate cancer

Integrative Genomics Identified RFC3 As an Amplified Candidate Oncogene in Esophageal Adenocarcinoma

Integrative genomic analyses identify BRF2 as a novel lineage-specific oncogene in lung squamous cell carcinoma

Author Correction: Gene isoforms as expression-based biomarkers predictive of drug response in vitro

Smoking status impacts microRNA mediated prognosis and lung adenocarcinoma biology

miR-101 DNA Copy Loss is a Prominent Subtype Specific Event in Lung Cancer

Unique Pattern of Component Gene Disruption in the NRF2 Inhibitor KEAP1/CUL3/RBX1 E3-Ubiquitin Ligase Complex in Serous Ovarian Cancer

Genetic Disruption of KEAP1/CUL3 E3 Ubiquitin Ligase Complex Components is a Key Mechanism of NF-KappaB Pathway Activation in Lung Cancer

Acquired Resistance to EGFR Inhibitors Is Associated with a Manifestation of Stem Cell-like Properties in Cancer Cells

Re: the Wnt signaling pathway in non-small cell lung cancer

ATM—the gene at the moment in non-small cell lung cancer

AhR controls redox homeostasis and shapes the tumor microenvironment in BRCA1-associated breast cancer

Mutant IDH1 Downregulates ATM and Alters DNA Repair and Sensitivity to DNA Damage Independent of TET2

Lysophosphatidic Acid Receptor 1 (LPA1) Antagonists as Potential Migrastatics for Triple Negative Breast Cancer

EZH2 Promotes E2F-Driven SCLC Tumorigenesis through Modulation of Apoptosis and Cell-Cycle Regulation

Suchergebnisse filtern